Heart Failure in Older Adults
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Heart failure (HF) is a leading cause of morbidity, hospitalization, and mortality in older adults, and a growing public health problem placing a huge financial burden on the health care system. Many challenges exist in the assessment and management of HF in geriatric patients, who often have co-existing multi-morbid illness, polypharmacy, cognitive impairment, and frailty. These complex ‘geriatric domains’ greatly affect physical and functional status as well as long-term clinical outcomes. Geriatric patients have been under-represented in major HF clinical trials. Nonetheless, available data suggest that guideline-based medical and device therapies improve morbidity and mortality. Non-pharmacological strategies, such as exercise training and dietary interventions, are an active area of research. Targeted geriatric evaluation including functional and cognitive assessment can improve risk stratification and guide management in older HF patients. Clinical trials that enroll multi-morbid older HF patients and evaluate functional status and quality of life in addition to mortality and cardiovascular morbidity should be encouraged to guide management of this age group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
A global clinical measure of fitness and frailty in elderly people
Rockwood, K. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050051 · Cited by 8,968
Angiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563
O'Connor (2009) · doi:10.1001/jama.2009.454 · Cited by 2,173 · cited 1×
“Only 19% of HF-ACTION participants were ≥ 70 years of age (72), but benefits appeared similar in elderly and younger HFrEF patients.”
BackgroundRates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
Juurlink, D. N., Mamdani, M. M., Lee, D. S., Kopp, A., Austin, P. C., Laupacis, A., & Redelmeier, D. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040135 · Cited by 1,761
Kitzman, D. W., Brubaker, P., Morgan, T., Haykowsky, M., Hundley, G., Kraus, W. E., Eggebeen, J., & Nicklas, B. J. (2016) · JAMA · doi:10.1001/jama.2015.17346 · Cited by 921
Batsis, J. A., Mackenzie, T. A., Barre, L. K., Lopez-Jimenez, F., & Bartels, S. J. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.117 · Cited by 479 · cited 1×
“Low body mass index (BMI) is a well-known risk factor for death in HF, but many older adults in Western countries have sarcopenic obesity, or muscle wasting despite increased BMI (80).”
BackgroundRandomised Controlled Trial of Cardiac Rehabilitation in Elderly Patients with Heart Failure
Austin, J., Williams, R., Ross, L., Moseley, L., & Hutchison, S. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.10.004 · Cited by 251 · cited 1×
“study of 200 stable HFrEF patients demonstrated that a 24-week multidisciplinary cardiac rehabilitation program improved functional capacity and quality of life while reducing overall hospital days (71).”
BackgroundChanging preferences for survival after hospitalization with advanced heart failure
Stevenson, L. W., Hellkamp, A. S., Leier, C. V., Sopko, G., Koelling, T., Warnica, J. W., Abraham, W. T., Kasper, E. K., Rogers, J. G., Califf, R. M., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.028 · Cited by 164 · cited 1×
“In one large study three-quarters of elderly HF outpatients were unwilling to trade any survival time for improved quality of life (85), and preferences can change over the course of illness in HF (86).”
BackgroundChiarantini, D., Volpato, S., Sioulis, F., Bartalucci, F., Del Bianco, L., Mangani, I., Pepe, G., Tarantini, F., Berni, A., Marchionni, N., et al. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.01.004 · Cited by 157
Patel, A., Parikh, R., Howell, E. H., Hsich, E., Landers, S. H., & Gorodeski, E. Z. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.001438 · Cited by 133
Jefferson, K., Ahmed, M., Choleva, M., Mak, S., Allard, J. P., Newton, G. E., & Arcand, J. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.10.002 · Cited by 55
Dietary Sodium Restriction in Heart Failure: A Recommendation Worth its Salt? ∗
Hummel, S. L., & Konerman, M. C. (2016) · JACC: Heart Failure · doi:10.1016/j.jchf.2015.10.003 · Cited by 14
Self-citation
Cited by
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Mota-Gomes, M. A., Brandão, A. A., Feitosa, A. D. D. M., Machado, C. A., Poli-de-Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,068
Hypertension Management in Older and Frail Older Patients
Benetos, A., Petrovic, M., & Strandberg, T. (2019) · Circulation Research · doi:10.1161/circresaha.118.313236 · Cited by 508
Transforming growth factor-β in myocardial disease
Frangogiannis, N. G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00646-w · Cited by 344
Metadata
- Authors
- Butrous, H., & Hummel, S. L.
- Venue
- Canadian Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 32
- Issue
- 9
- Pages
- 1140-1147
- ISSN
- 0828-282X (ISSN-L)
- OpenAlex
- W2366275743
- Cited by
- 144
- References
- 18
- FWCI
- 7.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.